Pulmonology Pulmonology
Pulmonol 2018;24:99-105 - Vol. 24 Num.2 DOI: 10.1016/j.rppnen.2017.11.007
Review
Migration, TB control and elimination: Whom to screen and treat
A. Rendona,1, R. Centisb, J.-P. Zellwegerc,1, I. Solovicd, C.A. Torres-Duquee, C. Robalo Cordeirof, F.C. de Queiroz Mellog, D. Manisseroh,1, G. Sotgiui,1,,
a Center for Research, Prevention and Treatment of Respiratory Infections, University Hospital of Monterrey, UANL, Monterrey, Mexico
b World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy
c TB Competence Center, Swiss Lung Association, Berne, Switzerland
d National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Slovakia
e Fundación Neumológica Colombiana, Universidad de La Sabana, Bogotá, Colombia
f Pulmonology Department, Coimbra University Hospital, Faculty of Medicine of Coimbra, Coimbra, Portugal
g Thoracic Diseases Institute, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
h University College of London, Institute for Global Health, London, United Kingdom
i Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
Received 16 November 2017, Accepted 27 November 2017
Abstract

Tuberculosis (TB) in migrants represents an important clinical and public health threat, particularly in low TB incidence countries. The current review is aimed to assess issues related to screening and treatment of migrants with latent TB infection or TB disease.

Keywords
TB migrants, TB elimination, TB control screening
Pulmonol 2018;24:99-105 - Vol. 24 Num.2 DOI: 10.1016/j.rppnen.2017.11.007